Cargando…
Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions
Drug-eluting stents (DES) are widely used as first choice devices in percutaneous coronary interventions. However, certain concerns are associated with the use of DES, i.e. delayed arterial healing with a subsequent risk of neo-atherosclerosis, late stent thrombosis and hypersensitivity reactions to...
Autores principales: | Felix, Cordula, Everaert, Bert, Diletti, Roberto, Van Mieghem, Nicolas, Daemen, Joost, Valgimigli, Marco, de Jaegere, Peter P., Zijlstra, Felix, Regar, Evelyn, Simsek, Cihan, Onuma, Yoshinobu, van Geuns, Robert-Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352158/ https://www.ncbi.nlm.nih.gov/pubmed/25626697 http://dx.doi.org/10.1007/s12471-015-0652-2 |
Ejemplares similares
-
Angiographic and Optical Coherence Tomography Insights Into Bioresorbable Scaffold Thrombosis: Single-Center Experience
por: Karanasos, Antonios, et al.
Publicado: (2015) -
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017) -
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users: A position statement on the use of bioresorbable vascular scaffolds in the Netherlands
por: Everaert, Bert, et al.
Publicado: (2015) -
Very late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy
por: Karanasos, Antonios, et al.
Publicado: (2014) -
Serial invasive imaging follow‐up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)